Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methotrexate. A single agent for early abortion

E A Schaff1, U Penmetsa, S H Eisinger

  • 1Department of Family Medicine, University of Rochester, NY 14620, USA.

The Journal of Reproductive Medicine
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body mass index and health status in diabetic and non-diabetic individuals.

Nutrition & diabetes·2015
Same author

Management of borderline change in endocervical cells: a more dependable approach.

British journal of cancer·2014
Same author

Alcohol consumption and risk of type 2 diabetes in European men and women: influence of beverage type and body size The EPIC-InterAct study.

Journal of internal medicine·2012
Same author

Bladder tumour diagnosed in a case presenting with uterine leiomyoma and hydronephrosis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2009
Same author

Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians.

Diabetologia·2005
Same author

Racial/ethnic inequities in continuity and site of care: location, location, location.

Health services research·2005
Same journal

Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic.

The Journal of reproductive medicine·2022
Same journal

Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report.

The Journal of reproductive medicine·2018
Same journal

Isolated Recurrent Hematotrachelos After Abdominal Myomectomy A Case Report.

The Journal of reproductive medicine·2018
Same journal

Live Birth from Electively Cryopreserved Oocytes: A Feasible Option for Couples Opposed to Embryo Cryopreservation A Case Report.

The Journal of reproductive medicine·2018
Same journal

Prevalence and Risk Factors of Ejaculation Failure on the Day of Operation Among Chinese Males Undergoing Assisted Reproductive Technique Treatments.

The Journal of reproductive medicine·2018
Same journal

Efficacy and Safety of Perioperative Use of Epinephrine for Laparoscopic Myomectomy in Infertile Women with Symptomatic Solitary Intramural Uterine Fibroids A Randomized Clinical Trial.

The Journal of reproductive medicine·2018
See all related articles

Methotrexate alone for early pregnancy termination is effective but takes longer and does not reduce side effects compared to the methotrexate and misoprostol combination. Some women required misoprostol for successful abortion.

Area of Science:

  • Reproductive Medicine
  • Pharmacology

Background:

  • Medical abortion is a common method for early pregnancy termination.
  • Methotrexate and misoprostol are frequently used in combination for this procedure.

Purpose of the Study:

  • To compare the efficacy, side effects, and acceptability of methotrexate as a single agent versus the combination of methotrexate and misoprostol for induced abortion up to 5 weeks gestation.

Main Methods:

  • A comparative study involving women with early pregnancies (≤5 weeks gestation).
  • The study group received intramuscular methotrexate, with misoprostol offered only if abortion did not occur by day 21.
  • The control group received misoprostol within the first week after methotrexate.

Main Results:

Related Experiment Videos

  • While effective, methotrexate alone resulted in a significantly longer time to abortion compared to the combination therapy (mean 15.5 vs. 8.1 days).
  • 15% of women in the single-agent group ultimately required misoprostol for abortion.
  • No significant differences were observed in bleeding duration, gastrointestinal side effects, or subject satisfaction between the groups.

    • Conclusions:

    • Methotrexate as a single agent is effective for early pregnancy abortion but is less time-efficient than the combination regimen.
    • The combination of methotrexate and misoprostol appears to be a more efficient approach for medical abortion in early pregnancy.
    • Single-agent methotrexate did not demonstrate fewer side effects or greater acceptability compared to the combined regimen.